A clinical trial to study the effects of preoperative use of Tapentadol 75mg for postoperative pain relief in laparoscopic cholecystectomy
Phase 4
- Conditions
- Health Condition 1: null- Age between 18 and 60 yrs,ASA I & II,Both male and female,Patients undergoing lap cholecystectomy
- Registration Number
- CTRI/2014/05/004621
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
patients aged between 18 to 60 yrs with ASA I & II,
Of either sex, undergoing lap cholecystectomy were included
Exclusion Criteria
Pt with impaired kidney or liver functions,
H/o drug or alcohol abuse,
H/o chr pain or daily intake of analgesic,
Uncontrolled medical disease (DM & HTN),
H/o intake of NSAID within 24 h of surgery,
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total analgesic requirement <br/ ><br>Timepoint: 24hr postoperatively.
- Secondary Outcome Measures
Name Time Method time of first analgesic requirement, incidence of postoperative pain in terms of VAS score and side effects if any.Timepoint: incidence of postoperative pain in terms of VAS score at 0, 2,4,8,12 and 24hr postoperatively and <br/ ><br>side effects if any during 24hr postoperatively.